Search Results 1231-1240 of 21239 for Informed consent

1. A Study of Contribution of 3D Models in Resection of Renal Cell Cancer - Mayo Clinic

   Ability to provide written, informed consent prior to initiation of any study-related procedures, and ability, in the opinion of the principle investigator, to ...

2. Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

   Provide written informed consent. Willingness to provide mandatory blood specimens and bone marrow specimens for correlative research. Willingness to return ...

3. Analysis to Identify Biomarkers Associated With ADPKD - Mayo Clinic

   Unable to provide informed consent. Prior renal transplant. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 8 ...

4. Paclitaxel-Coated Pulmonary Balloon For The Treatment Of Benign Central Airway Stenosis - Mayo Clinic

   Willing and able to provide written informed consent. Exclusion Criteria:1. Two or more clinically significant (e.g. non-traversable) stenoses with total ...

5. Masculinizing surgery - Mayo Clinic

   Consent. Because masculinizing surgery might cause physical changes that cannot be reversed, you must give informed consent after thoroughly discussing:.

6. MMRF Molecular Profiling Protocol - Mayo Clinic

   Procedure-specific signed informed consent form prior to initiation of any study-related procedures. Exclusion Criteria: It is the enrolling study ...

7. E-Mindfulness Approaches For Living After Breast Cancer - Mayo Clinic

   * The participant or a legally authorized representative must provide study-specific informed consent prior to pre-entry and, for participants treated in ...

8. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

   Signed informed consent prior to any study-mandated procedure; Signs or symptoms of Heart Failure (HF) (NYHA FC I I and II I ) requiring treatment with at ...

9. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   Active clinical relapse between providing informed consent and enrollment (ie, date of the first dose of ATA188); Concurrent serious uncontrolled or ...

10. Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer - Mayo Clinic

    - Has written informed consent. - Willingness to return to NCCTG enrolling institution for treatment and follow-up. - Patient willing to provide blood ...